— Know what they know.
Not Investment Advice

IRWD NASDAQ

Ironwood Pharmaceuticals, Inc.
1W: -11.9% 1M: -17.5% 3M: -16.9% YTD: -14.8% 1Y: +149.3% 3Y: -62.2% 5Y: -72.9%
$3.64
-0.12 (-3.19%)
 
Weekly Expected Move ±6.3%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · $599.2M mcap · 158M float · 1.38% daily turnover · Short 51% of daily vol

Supply Chain Overview

4 relationships
4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-05-22
Earliest Filing
2025-12-23
Latest Filing
partner: 2 target: 2

Counterparties (Filed by IRWD)

4 relationships

Companies named in IRWD's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Ferring International Center S.A. — partner Licensee and counterparty in an amended exclusive license agreement and settlement. 2025-12-23 View
COUR Pharmaceutical Development Company, Inc. COUR partner Partner in a terminated collaboration and license option agreement for CNP-104. 2024-09-30 View
VectivBio Holding AG — target Target of Ironwood's cash tender offer and subsequent merger. 2023-06-30 View
VectivBio Holding AG — target Target of Ironwood's cash tender offer and subsequent merger. 2023-05-22 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-06 Earnings Release; Exhibits View
2026-06-18 Officer/Director Change; Shareholder Vote; Exhibits View
2026-06-15 Other Events View
2026-05-21 Officer/Director Change View
2026-05-13 Officer/Director Change View
2026-05-07 Earnings Release; Exhibits View
2026-03-11 Other Events View
2026-02-25 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-02 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-12-23 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-11-26 Other Events View
2025-11-10 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-10 Departure/Election of Directors; Appointment of Officers View
2025-09-03 Other Events View
2025-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-10 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2025-06-12 Submission of Matters to a Vote of Security Holders View
2025-06-03 Notice of Delisting or Transfer View
2025-05-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-25 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms